Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APHA
3201
DELISTED
Aphria Inc. Common Shares
APHA
| $803K | ﹤0.01% |
187,542
+148,144
| +376% | +$568K |
|
|
FLNA
3202
Filana Therapeutics
FLNA
$48.8M
| $802K | ﹤0.01% |
260,579
+149,082
| +134% | +$676K |
|
3203
MakeMyTrip
MMYT
$5.36B
| $801K | ﹤0.01% |
52,313
+1,405
| +3% | +$20.8K |
|
|
DMTK
3204
DELISTED
DermTech, Inc. Common Stock
DMTK
| $801K | ﹤0.01% |
+60,579
| New | +$789K |
|
3205
Qfin Holdings
QFIN
$1.69B
| $800K | ﹤0.01% |
74,815
+32,530
| +77% | +$296K |
|
3206
Orion Group Holdings
ORN
$396M
| $799K | ﹤0.01% |
254,680
| – | – |
|
3207
TFI International
TFII
$11.1B
| $791K | ﹤0.01% |
22,318
+2,729
| +14% | +$77.6K |
|
3208
Schwab International Equity ETF
SCHF
$66.6B
| – | – |
0
| – | – |
|
3209
Imunon
IMNN
$6.68M
| $789K | ﹤0.01% |
1,085
+754
| +228% | +$327K |
|
|
FSFG
3210
DELISTED
First Savings Financial Group
FSFG
| $784K | ﹤0.01% |
54,282
+37,356
| +221% | +$533K |
|
3211
PAVmed
PAVM
$35.4M
| $781K | ﹤0.01% |
823
+612
| +290% | +$612K |
|
3212
Airgain
AIRG
$73.4M
| $780K | ﹤0.01% |
72,662
-50,323
| -41% | -$430K |
|
|
EVLO
3213
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $779K | ﹤0.01% |
7,954
+882
| +12% | +$77.2K |
|
3214
Security National Financial
SNFCA
$244M
| $777K | ﹤0.01% |
158,351
+78,111
| +97% | +$338K |
|
3215
Stratasys
SSYS
$679M
| $776K | ﹤0.01% |
48,941
-308,086
| -86% | -$5.21M |
|
|
CEMI
3216
DELISTED
Chembio diagnostics, Inc.
CEMI
| $776K | ﹤0.01% |
239,025
+120,526
| +102% | +$1.14M |
|
3217
Mayville Engineering Co
MEC
$654M
| $775K | ﹤0.01% |
98,224
+2,396
| +3% | +$14.7K |
|
3218
InMode
INMD
$870M
| $772K | ﹤0.01% |
54,570
+4,484
| +9% | +$60K |
|
|
BRFS
3219
DELISTED
BRF SA
BRFS
| $771K | ﹤0.01% |
194,335
+44,957
| +30% | +$173K |
|
3220
Kopin
KOPN
$652M
| $770K | ﹤0.01% |
579,661
+38,140
| +7% | +$31.9K |
|
|
HTZ
3221
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $769K | ﹤0.01% |
545,707
-858,717
| -61% | -$2.73M |
|
3222
ReposiTrak
TRAK
$153M
| $768K | ﹤0.01% |
181,753
+82,968
| +84% | +$400K |
|
|
BHR
3223
Braemar Hotels & Resorts
BHR
$156M
| $761K | ﹤0.01% |
266,314
-189,277
| -42% | -$549K |
|
|
QIWI
3224
DELISTED
QIWI PLC
QIWI
| $759K | ﹤0.01% |
43,838
+2,308
| +6% | +$31.3K |
|
3225
STMicroelectronics
STM
$46.7B
| $758K | ﹤0.01% |
27,657
-3,891
| -12% | -$96.7K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.